Cargando…
Effects of 1,25-Dihydroxycholecalciferol on Recovery and Resolution of Late Transient Neonatal Hypocalcemia
Background. Late transient neonatal hypocalcemia with hyperphosphatemia is potentially life-threatening. The use of 1.25 dihydroxycholecalciferol in the management of neonatal hypocalcemia is unexplored. Objective. We hypothesized adding 1.25 dihydroxycholecalciferol to intravenous continuous calciu...
Autores principales: | Amaral, Jennifer M., Abrams, Steve, Karaviti, Lefkothea, McKay, Siripoom V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842895/ https://www.ncbi.nlm.nih.gov/pubmed/20339510 http://dx.doi.org/10.1155/2010/409670 |
Ejemplares similares
-
Estimation of Serum 1,25-Dihydroxycholecalciferol and Tumor Necrosis Factor-α Levels in Chronic Periodontitis
por: Dhulipalla, Ravindranath, et al.
Publicado: (2023) -
1,25-Dihydroxycholecalciferol Improved the Growth Performance and Upregulated the Calcium Transporter Gene Expression Levels in the Small Intestine of Broiler Chickens
por: Wu, Lihua, et al.
Publicado: (2022) -
Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines
por: Alatawi, Fatema Suliman, et al.
Publicado: (2023) -
Late-Onset Neonatal Hypocalcemia Due to Transient Hypoparathyroidism in Infant of Mother With COVID-19 at Delivery
por: Grundman, Jody B, et al.
Publicado: (2021) -
25-Hydroxy- and 1α,25-Dihydroxycholecalciferol Have Greater Potencies than 25-Hydroxy- and 1α,25-Dihydroxyergocalciferol in Modulating Cultured Human and Mouse Osteoblast Activities
por: Zarei, Allahdad, et al.
Publicado: (2016)